Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 7861 AL 7875

Guardians of homeostasis: Natural products target metabolic reprogramming in Alzheimer's disease

Zhang Z, Xu H, Zhao F, Han Z, Pan J, Li M, Guan W, Jiang P, Hao Z, Zhang Y, Ma X, Kuang H, Liu Y.

Ageing Res Rev. 2026 Jan;114:103005. doi: 10.1016/j.arr.2025.103005. Epub 2025 Dec 24.

Micro- and Nanoplastics and Functional Nutrients in Human Health: Epigenetic Mechanisms and Cellular Resilience Signaling in Brain Insulin Resistance and the Risk of Alzheimer's Disease

Lombardo C, Musso N, Bonacci PG, Lupo G, Anfuso CD, Di Fatta E, Ferri R, Majzúnová M, Scuto MC, Trovato Salinaro A.

Int J Mol Sci. 2025 Dec 23;27(1):169. doi: 10.3390/ijms27010169.

Antimicrobial peptides inhibit Tau aggregation and modulates its pathology

Chinnathambi S, Rangappa N, Malik S.

Adv Protein Chem Struct Biol. 2026;149:375-394. doi: 10.1016/bs.apcsb.2025.09.002. Epub 2025 Oct 8.

Antibodies targeting amyloid-β and Tau oligomers in Alzheimer's disease

Chinnathambi S, Rangappa N, Chandrashekar M.

Adv Protein Chem Struct Biol. 2026;151:225-265. doi: 10.1016/bs.apcsb.2025.10.002. Epub 2025 Nov 5.

Paratonia in dementia: diagnosis and management strategies

Joshi S, Chutia P, Tripathi SM.

Neurodegener Dis Manag. 2026 Apr;16(2):173-176. doi: 10.1080/17582024.2025.2591413. Epub 2025 Nov 18.

Dampening of Microglial Activation With Nasal Foralumab Administration in Moderate Alzheimer's Disease Dementia

Singhal T, Cicero S, Gale SA, Horan N, Dubey S, Marshall GA, Weiner HL.

Clin Nucl Med. 2025 Aug 1;50(8):756-757. doi: 10.1097/RLU.0000000000005955. Epub 2025 May 13.

Multiple ischemic strokes in a patient treated with Lecanemab: a case report

Alammar H, Diallo M, Llano DA.

Neurocase. 2025 Dec;31(6):295-300. doi: 10.1080/13554794.2025.2566151. Epub 2025 Oct 16.

Endoscopic Retrieval of Ingested Button Battery From a Colonic Diverticulum in an Alzheimer's Patient: A Case Report

Hizukuri K, Fujita Y, Amagai T.

Am J Case Rep. 2025 Dec 3;26:e949004. doi: 10.12659/AJCR.949004.

Differences in baseline cognitive performance between participants with early-onset and late-onset Alzheimer's disease: Comparison of LEADS and ADNI

Hammers DB, Eloyan A, Thangarajah M, Taurone A, Beckett L, Gao S, Polsinelli AJ, Kirby K, Dage JL, Nudelman K, Aisen P, Reman R, La Joie R, Lagarde J, Atri A, Clark D, Day GS, Duara R, Graff-Radford NR, Honig LS, Jones DT, Masdeu JC, Mendez MF, Womack K, Musiek E, Onyike CU, Riddle M, Grant I, Rogalski E, Johnson ECB, Salloway S, Sha SJ, Turner RS, Wingo TS, Wolk DA, Carrillo MC, Dickerson BC, Rabinovici GD, Apostolova LG; LEADS Consortium 1 for the Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2025 Jan;21(1):e14218. doi: 10.1002/alz.14218. Epub 2024 Dec 23.

Identification of the binding site and immunoreactivity of anti-Aβ antibody 11A1: Comparison with the toxic conformation-specific TxCo-1 antibody

Fukui R, Hafizal U, Kageyama Y, Irie Y, Matsushima Y, Hosoi K, Nakayama T, Kaneda D, Hashizume Y, Miki K, Kita A, Mukaisho KI, Kushima R, Tooyama I, Irie K.

Biochem Biophys Res Commun. 2025 Apr 12;758:151655. doi: 10.1016/j.bbrc.2025.151655. Epub 2025 Mar 17.

Comparing clinical features of behavioral variant frontotemporal dementia and Alzheimer's disease using network analysis

Goodwin GJ, Mehrzad S, Cummings JL, Renn BN, Kinney JW, John SE.

Alzheimers Dement. 2025 Jun;21(6):e70361. doi: 10.1002/alz.70361.

Comparing levetiracetam and zonisamide effects on rivastigmine anti-Alzheimer's activity in aluminum chloride-induced Alzheimer's-like disease in rats: Impact on α7 nicotinic acetylcholine receptors and amyloid β

Abdel-Aal RA, Meligy FY, Maghraby N, Sayed N, Mohamed Ashry IE.

Brain Res. 2025 May 15;1855:149573. doi: 10.1016/j.brainres.2025.149573. Epub 2025 Mar 15.

Comparing clinical effect sizes of Souvenaid(TM), lecanemab, and donanemab in early Alzheimer's disease

Solfrizzi V, Imbimbo BP.

J Alzheimers Dis. 2026 Feb;109(3):1258-1263. doi: 10.1177/13872877251406221. Epub 2025 Dec 22.

Clinical trials targeting tau should be halted

Olluri A.

J Clin Neurosci. 2025 Apr;134:111101. doi: 10.1016/j.jocn.2025.111101. Epub 2025 Feb 4.

Special Issue: "New Trends in Alzheimer's Disease Research: From Molecular Mechanisms to Therapeutics: 2nd Edition"

Cacabelos R.

Int J Mol Sci. 2025 Jul 25;26(15):7175. doi: 10.3390/ijms26157175.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias